Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 84
2019 89
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

147 results
Results by year
Filters applied: . Clear all
Page 1
Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti-androgens.
Katzer T, Leite Junior A, Beck R, da Silva C. Katzer T, et al. Dermatol Ther. 2019 Sep;32(5):e13059. doi: 10.1111/dth.13059. Epub 2019 Aug 26. Dermatol Ther. 2019. PMID: 31400254 Review.
Androgenetic alopecia (AGA) is the most diagnosed hair loss dysfunction. Its physiopathology comprises a genetic predisposition affording an exacerbated response of the hair follicles cells to androgens aggravated by scalp inflammation and extrinsic factors. ...
Androgenetic alopecia (AGA) is the most diagnosed hair loss dysfunction. Its physiopathology comprises a genetic predispositio
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
Manabe M, Tsuboi R, Itami S, Osada SI, Amoh Y, Ito T, Inui S, Ueki R, Ohyama M, Kurata S, Kono T, Saito N, Sato A, Shimomura Y, Nakamura M, Narusawa H, Yamazaki M; Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss. Manabe M, et al. J Dermatol. 2018 Sep;45(9):1031-1043. doi: 10.1111/1346-8138.14470. Epub 2018 Jun 4. J Dermatol. 2018. PMID: 29863806
Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. In 2010, we published the first Japanese edition of guidelines for the diagnosis and treatment of MPHL. ...Subsequently, ne
Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begin
Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R, Hermosa-Gelbard A, Moreno-Arrones OM, Fernandez-Nieto D, Vaño-Galvan S. Jimenez-Cauhe J, et al. J Am Acad Dermatol. 2019 Aug;81(2):648-649. doi: 10.1016/j.jaad.2019.04.054. Epub 2019 May 2. J Am Acad Dermatol. 2019. PMID: 31054970 No abstract available.
The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis.
Zhou Z, Song S, Gao Z, Wu J, Ma J, Cui Y. Zhou Z, et al. Clin Interv Aging. 2019 Feb 20;14:399-406. doi: 10.2147/CIA.S192435. eCollection 2019. Clin Interv Aging. 2019. PMID: 30863034 Free PMC article.
AIM: We performed a meta-analysis to evaluate the efficacy and safety of dutasteride and finasteride in treating men with androgenetic alopecia (AGA) during a 24-week treatment cycle. ...
AIM: We performed a meta-analysis to evaluate the efficacy and safety of dutasteride and finasteride in treating men with androgenetic
Minoxidil in the treatment of androgenetic alopecia.
Goren A, Naccarato T. Goren A, et al. Dermatol Ther. 2018 Sep;31(5):e12686. doi: 10.1111/dth.12686. Epub 2018 Aug 28. Dermatol Ther. 2018. PMID: 30155952 Review.
The National Institutes of Health (US NIH, 2018) estimates that in the US approximately 50 million men and 30 million women suffer from AGA (also known as pattern hair loss). Minoxidil is the only topical drug for the treatment of both female and male patt
The National Institutes of Health (US NIH, 2018) estimates that in the US approximately 50 million men and 30 million women suffer from AGA …
An overview of herbal alternatives in androgenetic alopecia.
Dhariwala MY, Ravikumar P. Dhariwala MY, et al. J Cosmet Dermatol. 2019 Aug;18(4):966-975. doi: 10.1111/jocd.12930. Epub 2019 Apr 13. J Cosmet Dermatol. 2019. PMID: 30980598 Review.
The second most common alopecia-Androgenetic alopecia (AGA)-occurs due to hormonal imbalance. Dihydrotestosterone (DHT) an androgenic hormone is a sex steroid, produced in the gonads. ...
The second most common alopecia-Androgenetic alopecia (AGA)-occurs due to hormonal imbalance. Dihydrotestosterone (DHT) …
What's New in Hair Loss.
Santos LDN, Shapiro J. Santos LDN, et al. Dermatol Clin. 2019 Apr;37(2):137-141. doi: 10.1016/j.det.2018.11.002. Dermatol Clin. 2019. PMID: 30850035 Review.
This article discusses the most recent literature updates on the use of retinoids in frontal fibrosing alopecia, platelet-rich plasma in androgenetic alopecia, and JAK inhibitors in alopecia areata....
This article discusses the most recent literature updates on the use of retinoids in frontal fibrosing alopecia, platelet-rich plasma …
Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
Gupta AK, Mays RR, Dotzert MS, Versteeg SG, Shear NH, Piguet V. Gupta AK, et al. J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2112-2125. doi: 10.1111/jdv.15081. Epub 2018 Jul 11. J Eur Acad Dermatol Venereol. 2018. PMID: 29797431
Androgenetic alopecia, or male/female pattern baldness, is the most common type of progressive hair loss disorder. The aim of this study was to review recent advances in non-surgical treatments for androgenetic alopecia and
Androgenetic alopecia, or male/female pattern baldness, is the most common type of progressive hai
147 results
Jump to page
Feedback